A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria
Clinical trial NCT05298215 · UNKNOWN
Trial details
- NCT number
- NCT05298215
- Sponsor
- United BioPharma
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2023-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.